BIO Bio-Rad Laboratories, Inc.
Healthcare$287.74+0.35%ClosedMarket Cap: $7.78B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$321.67
Target (Median)
$320.00
Target Range
$310.00 - $335.00
Upside from current price: 11.8%
Rating Distribution
1 Strong Buy0 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-01 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-04-07 | Citigroup | downgrade | Neutral | Buy |
| 2026-02-16 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-10-30 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-10-30 | Citigroup | maintain | Buy | Buy |
| 2025-08-01 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-08-01 | RBC Capital | maintain | Outperform | Outperform |
| 2025-06-09 | Wells Fargo | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $9.28 | $2.59B | 2 |
| Fri Dec 31 | $9.96 | $2.66B | 2 |
| Sun Dec 31 | $11.15 | $2.76B | 1 |
| Mon Dec 31 | $12.17 | $2.81B | 1 |